癌症登记软体市场规模、份额和成长分析（按类型、部署模式、资料库、功能、最终用户和地区划分）—2026-2033年产业预测

预计到 2024 年，癌症登记软体市场规模将达到 7,809 万美元，到 2025 年将成长至 8,629 万美元，到 2033 年将成长至 1.918 亿美元，在预测期（2026-2033 年）内复合年增长率为 10.5%。

癌症登记软体作为关键资料库，负责组织、收集和维护患者信息，用于评估治疗效果。在降低医疗成本和提高医疗品质的驱动下，对有效癌症管理的需求日益增长，推动了软体市场的显着成长。癌症登记资料在市场监测中的应用日益广泛，以及电子健康记录 (EHR) 的普及，进一步促进了市场扩张。此外，简化工作流程和减轻医生工作量也使得整合软体解决方案在医疗保健领域更具吸引力。政府对医疗管理的投入、对人口成长的关注以及监管倡议等关键因素，预计将加速癌症登记软体的普及，因为该软体具有许多营运优势。

癌症登记软体市场驱动因素

癌症登记系统的发展主要得益于各国政府机构为降低癌症发生率所做的努力。在全球范围内，各国政府机构正携手合作，推动医疗卫生体系的数位化和一体化，包括建立电脑化的疾病登记系统。这一趋势的驱动力源于对有效人群健康管理和医疗卫生资讯无缝交换日益增长的需求。这种整合不仅提高了资料收集的准确性，也促进了医疗服务提供者之间更紧密的合作，最终有助于改善病患预后，并提升医疗卫生系统的效率。

癌症登记软体市场的限制因素

由于对资料隐私和安全的担忧，癌症登记软体市场面临诸多製约。家庭详细资讯通常与健康记录关联，一旦发生资料洩露，患者及其亲属的敏感资讯很可能会被洩露。对于许多已开发国家的政府而言，情况更加复杂，他们既要确保资讯获取，又要保护个人隐私，这构成了一项艰鉅的挑战。透明的资料共用需求与保护敏感健康资讯的必要性之间的矛盾，给该领域的相关人员带来了巨大的挑战。

癌症登记软体市场趋势

受肿瘤治疗领域对高效数据管理需求的日益增长的推动，癌症登记软体市场正经历显着增长。随着全球医疗机构认识到详细癌症数据对于监测、治疗计划和患者预后的重要性，先进的登记软体系统应用显着增加。医疗保健领域技术的日益融合，尤其是对即时分析、增强报告功能和全面患者追踪的重视，也推动了这一趋势。此外，监管压力和对提高数据准确性的需求进一步促进了癌症登记软体的应用，强化了其在临床实践和人群健康管理中的关键作用。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析及其影响

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 技术进步
• 监管环境
• 专利分析
• 价值链分析
• 案例研究分析
• PESTEL 分析
• 总体经济指标

全球癌症登记软体市场规模（按类型和复合年增长率划分）（2026-2033 年）

• 独立软体
• 整合软体

全球癌症登记软体市场规模（按部署模式和复合年增长率划分）（2026-2033 年）

• 本地部署
• 基于云端的

全球癌症登记软体市场规模（按资料库和复合年增长率划分）（2026-2033 年）

• 商业资料库
• 公共资料库

全球癌症登记软体市场规模（按功能和复合年增长率划分）（2026-2033 年）

• 出于州和联邦监管目的的癌症报告
• 患者照护管理
• 产品结果评估
• 医学研究和临床试验

全球癌症登记软体市场规模（依最终用户划分）及复合年增长率（2026-2033 年）

• 政府机构和第三方管理机构（TPAS）
• 医院和医疗机构
• 製药、生技和医疗设备公司
• 私人保险公司
• 研究所

全球癌症登录软体市场规模及复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 英国
  • 德国
  • 西班牙
  • 法国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2021-2023年营收年比比较

主要企业简介

• IBM Watson Health
• Oracle Corporation
• Siemens Healthineers
• Cerner Corporation
• Epic Systems Corporation
• MEDITECH
• Allscripts Healthcare Solutions
• McKesson Corporation
• Philips Healthcare
• GE Healthcare
• Inova Health System
• Varian Medical Systems
• Roche Diagnostics
• TomoTherapy Inc.
• Health Information Systems
• Elekta
• ONCO, Inc.
• Conduent, Inc.
• Ordinate Corporation
• Volpara Health Limited

结论与建议

Cancer Registry Software Market size was valued at USD 78.09 Million in 2024 and is poised to grow from USD 86.29 Million in 2025 to USD 191.8 Million by 2033, growing at a CAGR of 10.5% during the forecast period (2026-2033).

Cancer registry software serves as a crucial database for organizing, collecting, and maintaining patient information to evaluate treatment outcomes. The market for such software is witnessing significant growth driven by the increasing need for effective cancer management, alongside a push to reduce healthcare costs while improving care quality. The rising utilization of cancer patient registry data for marketing surveillance, coupled with the broader adoption of electronic health records (EHRs), further propels market expansion. Additionally, streamlined workflows and reduced physician workloads enhance the appeal of integrated software solutions within healthcare. Key factors such as government investments in health management, population growth focus, and initiatives by regulatory agencies will likely accelerate the adoption of cancer registry software, driven by its numerous operational advantages.

Top-down and bottom-up approaches were used to estimate and validate the size of the Cancer Registry Software market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Cancer Registry Software Market Segments Analysis

Global Cancer Registry Software Market is segmented by Type, Deployment Model, Database, Functionality, end user and region. Based on Type, the market is segmented into Standalone Software, Integrated Software. Based on Deployment Model, the market is segmented into On-premises, Cloud-based. Based on Database, the market is segmented into Commercial Databases, Public Databases. Based on Functionality, the market is segmented into Cancer Reporting to Meet State & Federal Regulations, Patient Care Management, Product Outcome Evaluation, Medical Research and Clinical Studies. Based on end user, the market is segmented into Government Organizations & Third-party Administrators (TPAS), Hospitals & Medical Practices, Pharmaceutical, Biotechnology, & Medical Device Companies, Private Payers, Research Centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Cancer Registry Software Market

The development of cancer registries is significantly supported by initiatives from various government agencies focused on decreasing cancer prevalence. There is a concerted effort by governmental organizations globally to digitize and unify healthcare frameworks, which includes the establishment of computerized disease registries. This movement is driven by the increasing need for effective population health management and the seamless exchange of health information. Such integration not only enhances the accuracy of data collection but also fosters better coordination among healthcare providers, ultimately contributing to improved patient outcomes and a more efficient healthcare system.

Restraints in the Cancer Registry Software Market

The Cancer Registry Software market faces significant restraint due to concerns surrounding data privacy and security. Family member details are often linked to health records, raising the stakes in the event of a data breach, as sensitive information about patients and their relatives could be exposed. This situation is further complicated for governments in numerous advanced economies, which struggle to navigate the complexities of ensuring information accessibility while simultaneously safeguarding individual privacy. The tension between the need for transparent data sharing and the imperative to protect confidential health information presents a formidable challenge for stakeholders in this sector.

Market Trends of the Cancer Registry Software Market

The Cancer Registry Software market is witnessing a significant upswing driven by the increasing need for effective data management in oncology care. As healthcare organizations globally recognize the importance of detailed cancer data for research, treatment planning, and patient outcomes, there is a marked rise in the adoption of advanced registry software systems. This trend is supported by the growing integration of technology in healthcare, emphasizing real-time analytics, enhanced reporting capabilities, and comprehensive patient tracking. Additionally, regulatory pressures and the need for improved data accuracy further propel cancer registry software's usage, reinforcing its critical role in both clinical settings and population health management.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Technological Advancement
• Regulatory Landscape
• Patent Analysis
• Value Chain Analysis
• Case Study Analysis
• PESTEL Analysis
• Macro-Economic Indicators

Global Cancer Registry Software Market Size by Type & CAGR (2026-2033)

• Market Overview
• Standalone Software
• Integrated Software

Global Cancer Registry Software Market Size by Deployment Model & CAGR (2026-2033)

• Market Overview
• On-premises
• Cloud-based

Global Cancer Registry Software Market Size by Database & CAGR (2026-2033)

• Market Overview
• Commercial Databases
• Public Databases

Global Cancer Registry Software Market Size by Functionality & CAGR (2026-2033)

• Market Overview
• Cancer Reporting to Meet State & Federal Regulations
• Patient Care Management
• Product Outcome Evaluation
• Medical Research and Clinical Studies

Global Cancer Registry Software Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Government Organizations & Third-party Administrators (TPAS)
• Hospitals & Medical Practices
• Pharmaceutical, Biotechnology, & Medical Device Companies
• Private Payers
• Research Centers

Global Cancer Registry Software Market Size & CAGR (2026-2033)

• North America, (Type, Deployment Model, Database, Functionality, End-User)
  • US
  • Canada
• Europe, (Type, Deployment Model, Database, Functionality, End-User)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific, (Type, Deployment Model, Database, Functionality, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America, (Type, Deployment Model, Database, Functionality, End-User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa, (Type, Deployment Model, Database, Functionality, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• IBM Watson Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oracle Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cerner Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Epic Systems Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MEDITECH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Allscripts Healthcare Solutions
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• McKesson Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Philips Healthcare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Inova Health System
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Varian Medical Systems
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TomoTherapy Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Health Information Systems
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elekta
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ONCO, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Conduent, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ordinate Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Volpara Health Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation